LEUKEMIA AND LYMPHOMA, Detection of Minimal Residual Disease, 2003.pdf

L EUKEMIA

L YMPHOMA

Detection of Minimal

Residual Disease

EDITED BY

Theodore F. Zipf, PhD , MD

Dennis A. Johnston, PhD

HUMANA PRESS

A N D

L EUKEMIA AND L YMPHOMA

AND L YMPHOMA

Detection of Minimal

Residual Disease

Edited by

T HEODORE F. Z IPF , PhD , MD

Houston, TX

and

D ENNIS A. J OHNSTON , PhD

Department of Biomathematics, MD Anderson Cancer

Center

Houston, TX

H UMANA P RESS

T OTOWA , N EW J ERSEY

L EUKEMIA

999 Riverview Drive, Suite 208

Totowa, New Jersey 07512

For additional copies, pricing for bulk purchases, and/or information about other Humana titles,

contact Humana at the above address or at any of the following numbers: Tel: 973-256-1699;

Fax: 973-256-8341; E-mail: humana@humanapr.com or visit our website at http://www.humanapress.com

Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy

of the information published and to describe generally accepted practices. The contributors herein have

carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in

accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes

in government regulations, and knowledge from clinical experience relating to drug therapy and drug

reactions constantly occurs, the reader is advised to check the product information provided by the

manufacturer of each drug for any change in dosages or for additional warnings and contraindications.

This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is

the responsibility of the treating physician to determine dosages and treatment strategies for individual

patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug

Administration status of each drug or device used in their clinical practice. The publisher, editors, and

authors are not responsible for errors or omissions or for any consequences from the application of the

information presented in this book and make no warranty, express or implied, with respect to the

contents in this publication.

in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or

otherwise without written permission from the Publisher.

All articles, comments, opinions, conclusions, or recommendations are those of the author(s), and do not

necessarily reflect the views of the publisher.

This publication is printed on acid-free paper. ∞

ANSI Z39.48-1984 (American National Standards Institute)

Permanence of Paper for Printed Library Materials.

Cover design by Patricia F. Cleary.

Photocopy Authorization Policy:

Authorization to photocopy items for internal or personal use, or the internal or personal use of specific

clients, is granted by Humana Press Inc., provided that the base fee of US $10.00 per copy, plus US

$00.25 per page, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers,

MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate

system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of

the Transactional Reporting Service is: [0-89603-966-8/03 $10.00 + $00.25].

Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1

Library of Congress Cataloging-in-Publication Data

Leukemia and lymphoma: detection of minimal residual disease / edited by Theodore F. Zipf and Dennis

A. Johnston.

p.;cm.

Includes bibliographical references and index.

ISBN 0-89603-966-8 (alk. paper)

1. Leukemia–Molecular diagnosis. 2. Lymphomas–Molecular diagnosis. I. Zipf, Theodore F.

II. Johnston, Dennis A.

[DNLM: Neoplasm, Residual–diagnosis. 2. Leukemia. 3. Lymphoma. QZ 202 L652 2003]

RC643.L3724 2003

616.99'419075–dc21

2002024349

Plik z chomika:

Inne pliki z tego folderu:

Inne foldery tego chomika: